Recent Research Funding

Our faculty research in diverse subjects: psychosomatic issues, pain management, patient reporting and compliance behaviors, whole community and family roles in psychiatric conditions and treatment, teaching strategies and much more.

  • Strong Foundations: Intervening to Promote Co-Parenting and Reduce Father Hazardous Drinking in Expectant Parents. Kurt Dermen (Co-Investigator). National Institute on Alcohol Abuse and Alcoholism. $2,246,077. 5/1/2019-4/1/2024.
  • A 26-week, Multicenter, Open-label, Flexible-dose Study to Evaluate the Long-term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants with Schizophrenia or Bipolar I Disorder (3070-30-001), Abbvie. Steven Dubovsky (Principal Investigator). Abbvie. $150,000. 1/1/2021-12/1/2023.
  • A phase II randomized, double-blinded, placebo-controlled parallel group trial to examine the efficacy and safety of 4 oral doses of BI 1358894 once daily over 12 week treatment period in patients with borderline personality disorder, Boehringer Ingelheim. Steven Dubovsky (Principal Investigator). Boehringer Ingelheim. $200,000. 1/1/2021-12/1/2023.